Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

86 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation.
Fleeman N, Houten R, Bagust A, Richardson M, Beale S, Boland A, Dundar Y, Greenhalgh J, Hounsome J, Duarte R, Shenoy A. Fleeman N, et al. Among authors: bagust a. Health Technol Assess. 2020 Jan;24(2):1-180. doi: 10.3310/hta24020. Health Technol Assess. 2020. PMID: 31931920 Free PMC article.
Individualising breast cancer treatment to improve survival and minimise complications in older women: a research programme including the PLACE RCT.
Bundred N, Todd C, Morris J, Keeley V, Purushotham A, Bagust A, Foden P, Bramley M, Riches K. Bundred N, et al. Among authors: bagust a. Southampton (UK): NIHR Journals Library; 2019 Aug. NIHR Journals Library. 2019. PMID: 31436943 Free Books & Documents. Review.
Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Fleeman N, Bagust A, Duarte R, Richardson M, Nevitt S, Boland A, Kotas E, McEntee J, Thorp N. Fleeman N, et al. Among authors: bagust a. Pharmacoecon Open. 2019 Sep;3(3):293-302. doi: 10.1007/s41669-018-0114-z. Pharmacoecon Open. 2019. PMID: 30742256 Free PMC article. Review.
Exploring the Effects of Early Censoring and Analysis of Clinical Trial Survival Data on Effectiveness and Cost-effectiveness Estimation through a Case Study in Advanced Breast Cancer.
Bagust A, Beale SJ. Bagust A, et al. Med Decis Making. 2018 Oct;38(7):789-796. doi: 10.1177/0272989X18790966. Epub 2018 Aug 20. Med Decis Making. 2018. PMID: 30125510
Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Stainthorpe A, Greenhalgh J, Bagust A, Richardson M, Boland A, Beale S, Duarte R, Kotas E, Banks L, Palmer D. Stainthorpe A, et al. Among authors: bagust a. Pharmacoeconomics. 2018 Oct;36(10):1153-1163. doi: 10.1007/s40273-018-0646-1. Pharmacoeconomics. 2018. PMID: 29600384 Free PMC article. Review.
Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Fleeman N, Abdulla A, Bagust A, Beale S, Richardson M, Stainthorpe A, Boland A, Kotas E, McEntee J, Palmer D. Fleeman N, et al. Among authors: bagust a. Pharmacoeconomics. 2018 Mar;36(3):289-299. doi: 10.1007/s40273-017-0592-3. Pharmacoeconomics. 2018. PMID: 29178025 Review.
Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Fleeman N, Bagust A, Boland A, Beale S, Richardson M, Krishan A, Stainthorpe A, Abdulla A, Kotas E, Banks L, Payne M. Fleeman N, et al. Among authors: bagust a. Pharmacoeconomics. 2017 Oct;35(10):1035-1046. doi: 10.1007/s40273-017-0504-6. Pharmacoeconomics. 2017. PMID: 28316007 Review.
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.
Greenhalgh J, Bagust A, Boland A, Dwan K, Beale S, Hockenhull J, Proudlove C, Dundar Y, Richardson M, Dickson R, Mullard A, Marshall E. Greenhalgh J, et al. Among authors: bagust a. Health Technol Assess. 2015 Jun;19(47):1-134. doi: 10.3310/hta19470. Health Technol Assess. 2015. PMID: 26134145 Free PMC article. Review.
Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.
Brown T, Pilkington G, Bagust A, Boland A, Oyee J, Tudur Smith C, Blundell M, Lai M, Martin Saborido C, Greenhalgh J, Dundar Y, Dickson R. Brown T, et al. Among authors: bagust a. Health Technol Assess. 2015 May;17(31):281-2. doi: 10.3310/hta17310-c201505. Health Technol Assess. 2015. PMID: 26061626 No abstract available.
Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective.
Fleeman N, Bagust A, Beale S, Boland A, Dickson R, Dwan K, Richardson M, Dundar Y, Davis H, Banks L. Fleeman N, et al. Among authors: bagust a. Pharmacoeconomics. 2015 Sep;33(9):893-904. doi: 10.1007/s40273-015-0276-9. Pharmacoeconomics. 2015. PMID: 25906420 Review.
86 results
Jump to page
Feedback